Cabaletta Bio, Inc. (CABA)
2.96
+0.28
(+10.45%)
USD |
NASDAQ |
Apr 02, 16:00
2.96
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Cash from Investing (Quarterly) : 49.80M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Savara, Inc. | -93.56M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.34M |
| Cash from Financing (Quarterly) | 8.332M |
| Free Cash Flow | -132.31M |
| Free Cash Flow Per Share (Quarterly) | -0.3538 |
| Free Cash Flow to Equity (Quarterly) | -36.87M |
| Free Cash Flow to Firm (Quarterly) | -34.99M |
| Free Cash Flow Yield | -56.70% |